BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25635006)

  • 1. Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary.
    Morrison VA; Hamlin P; Soubeyran P; Stauder R; Wadhwa P; Aapro M; Lichtman SM
    Ann Oncol; 2015 Jun; 26(6):1058-1068. PubMed ID: 25635006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper.
    Morrison VA; Hamlin P; Soubeyran P; Stauder R; Wadhwa P; Aapro M; Lichtman S
    J Geriatr Oncol; 2015 Mar; 6(2):141-52. PubMed ID: 25491101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology.
    Droz JP; Albrand G; Gillessen S; Hughes S; Mottet N; Oudard S; Payne H; Puts M; Zulian G; Balducci L; Aapro M
    Eur Urol; 2017 Oct; 72(4):521-531. PubMed ID: 28089304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches.
    Allen P
    Curr Oncol Rep; 2020 Aug; 22(11):114. PubMed ID: 32827063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical approach to diffuse large B cell lymphoma.
    Caimi PF; Hill BT; Hsi ED; Smith MR
    Blood Rev; 2016 Nov; 30(6):477-491. PubMed ID: 27596109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations for the Treatment of Diffuse Large B Cell Lymphoma in the Elderly.
    Khan Y; Brem EA
    Curr Hematol Malig Rep; 2019 Aug; 14(4):228-238. PubMed ID: 31228094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma.
    Ulu BU; Yiğenoğlu TN; Başcı S; Bakırtaş M; Şahin D; Darçın T; Yaman S; Bozan E; Seçilmiş S; Candır BA; Yıldız J; İskender D; Baysal NA; Çakar MK; Dal MS; Altuntaş F
    Leuk Res; 2021 Nov; 110():106700. PubMed ID: 34481125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcomes in diffuse large B cell lymphoma patients aged 70 years and older: a single-center experience with a literature review.
    Jung YH; Woo IS; Han CW
    Korean J Intern Med; 2015 Sep; 30(5):684-93. PubMed ID: 26354063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives.
    Chiappella A; Castellino A; Nicolosi M; Santambrogio E; Vitolo U
    Expert Rev Hematol; 2017 Apr; 10(4):289-297. PubMed ID: 28290728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curative intent therapy for DLBCL in the elderly.
    Tucci A; Masina L; Luminari S
    Leuk Lymphoma; 2024 May; 65(5):560-569. PubMed ID: 38206922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance therapy following induction chemoimmunotherapy in patients with diffuse large B-cell lymphoma: current perspective.
    Reddy NM; Thieblemont C
    Ann Oncol; 2017 Nov; 28(11):2680-2690. PubMed ID: 29045503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse Large B-Cell Lymphoma in the Elderly: Real World Outcomes of Immunochemotherapy in Asian Population.
    Byun JM; Lee JO; Kang B; Kim JW; Kim SH; Kim JW; Kim YJ; Lee KW; Bang SM; Lee JS
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):503-510.e3. PubMed ID: 27375158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating novel drugs to chemoimmunotherapy in diffuse large B-cell lymphoma.
    Chiappella A; Santambrogio E; Castellino A; Nicolosi M; Vitolo U
    Expert Rev Hematol; 2017 Aug; 10(8):697-705. PubMed ID: 28665232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy.
    Suzuki T; Maruyama D; Miyagi-Maeshima A; Nomoto J; Tajima K; Ito Y; Hatta S; Yuda S; Makita S; Fukuhara S; Munakata W; Suzuki T; Taniguchi H; Izutsu K; Kobayashi Y; Tobinai K
    Cancer Med; 2021 Aug; 10(15):5101-5109. PubMed ID: 34105893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse large B-cell lymphoma in very elderly patients: Towards best tailored treatment - A systematic review.
    Tavares A; Moreira I
    Crit Rev Oncol Hematol; 2021 Apr; 160():103294. PubMed ID: 33675907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy.
    Ciammella P; Filippi AR; Simontacchi G; Buglione M; Furlan C; Spina M; Tucci A; Rigacci L; Iotti C; Vitolo U; Ricardi U; Merli F
    Leuk Lymphoma; 2016 Nov; 57(11):2677-80. PubMed ID: 26926887
    [No Abstract]   [Full Text] [Related]  

  • 17. Older patients with early-stage diffuse large B-cell lymphoma: the role of consolidation radiotherapy after chemoimmunotherapy.
    Parikh RR; Yahalom J
    Leuk Lymphoma; 2017 Mar; 58(3):614-622. PubMed ID: 27685446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi.
    Merli F; Luminari S; Rossi G; Mammi C; Marcheselli L; Ferrari A; Spina M; Tucci A; Stelitano C; Capodanno I; Fragasso A; Baldini L; Bottelli C; Montechiarello E; Fogazzi S; Lamorgese C; Cavalli L; Federico M;
    Leuk Lymphoma; 2014 Jan; 55(1):38-43. PubMed ID: 23517562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma.
    Wagner-Johnston ND; Goy A; Rodriguez MA; Ehmann WC; Hamlin PA; Radford J; Thieblemont C; Suh C; Sweetenham J; Huang Y; Sullivan ST; Vandendries ER; Gisselbrecht C
    Leuk Lymphoma; 2015; 56(10):2863-9. PubMed ID: 25707288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-line therapy in diffuse large B-cell lymphoma (DLBCL): treatment patterns and outcomes in older patients receiving outpatient chemotherapy.
    Danese MD; Griffiths RI; Gleeson ML; Dalvi T; Li J; Mikhael JR; Deeter R; Dreyling M
    Leuk Lymphoma; 2017 May; 58(5):1094-1104. PubMed ID: 27659997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.